Login
From:
Eli Lilly and Company
(Uncensored)
subscribe
Lilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease | Eli Lilly and Company
https://investor.lilly.com/news-releases/news-release-details/lillys-donanemab-significantly-slowed-cognitive-and-functional
links
backlinks
Roast topics
Find topics
Find it!
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
